Alpha Teknova (TKNO) Competitors

Alpha Teknova (NASDAQ:TKNO) and Adaptive Biotechnologies (NASDAQ:ADPT) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, community ranking, media sentiment, institutional ownership, risk, valuation, profitability and dividends.

Do analysts rate TKNO or ADPT?

Alpha Teknova currently has a consensus price target of $8.50, indicating a potential upside of 30.77%. Adaptive Biotechnologies has a consensus price target of $9.83, indicating a potential upside of 8.18%. Given Alpha Teknova's stronger consensus rating and higher probable upside, research analysts clearly believe Alpha Teknova is more favorable than Adaptive Biotechnologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alpha Teknova	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00
Adaptive Biotechnologies	0 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.83

Do insiders and institutionals believe in TKNO or ADPT?

13.8% of Alpha Teknova shares are held by institutional investors. Comparatively, 99.2% of Adaptive Biotechnologies shares are held by institutional investors. 15.2% of Alpha Teknova shares are held by insiders. Comparatively, 6.4% of Adaptive Biotechnologies shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Does the MarketBeat Community believe in TKNO or ADPT?

Adaptive Biotechnologies received 91 more outperform votes than Alpha Teknova when rated by MarketBeat users. Likewise, 58.14% of users gave Adaptive Biotechnologies an outperform vote while only 39.13% of users gave Alpha Teknova an outperform vote.

Company	Underperform	Outperform
Alpha Teknova	Outperform Votes 9 39.13%	Underperform Votes 14 60.87%
Adaptive Biotechnologies	Outperform Votes 100 58.14%	Underperform Votes 72 41.86%

Does the media prefer TKNO or ADPT?

In the previous week, Adaptive Biotechnologies had 8 more articles in the media than Alpha Teknova. MarketBeat recorded 9 mentions for Adaptive Biotechnologies and 1 mentions for Alpha Teknova. Alpha Teknova's average media sentiment score of 1.68 beat Adaptive Biotechnologies' score of 1.50 indicating that Alpha Teknova is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Alpha Teknova	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Adaptive Biotechnologies	8 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Is TKNO or ADPT more profitable?

Alpha Teknova has a net margin of -87.17% compared to Adaptive Biotechnologies' net margin of -89.12%. Alpha Teknova's return on equity of -35.30% beat Adaptive Biotechnologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alpha Teknova	-87.17%	-35.30%	-24.52%
Adaptive Biotechnologies	-89.12%	-64.65%	-26.45%

Which has more volatility & risk, TKNO or ADPT?

Alpha Teknova has a beta of 0.5, indicating that its share price is 50% less volatile than the S&P 500. Comparatively, Adaptive Biotechnologies has a beta of 1.75, indicating that its share price is 75% more volatile than the S&P 500.

Which has higher valuation & earnings, TKNO or ADPT?

Alpha Teknova has higher earnings, but lower revenue than Adaptive Biotechnologies. Alpha Teknova is trading at a lower price-to-earnings ratio than Adaptive Biotechnologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alpha Teknova	$38.25M	9.08	-$36.78M	-$0.48	-13.54
Adaptive Biotechnologies	$189.53M	7.29	-$159.49M	-$0.96	-9.47

Summary

Alpha Teknova beats Adaptive Biotechnologies on 10 of the 18 factors compared between the two stocks.